Physician profile
Milind Patel
NPI 1063831584
$3,191.06
in general payments reported to CMS, 2019-2025
16 companies · $398 in 2025
The $398 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $138 · 2022: $438 · 2023: $166 · 2024: $1,596 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,160.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,244.20 | 2022-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Endurant Iis |
| Stryker Corporation | $335.90 | 2024 | Everest Spinal System, Vitoss |
| Abbott Laboratories | $319.56 | 2019-2025 | Proclaim |
| Nevro Corp. | $258.19 | 2022-2024 | Senza |
| Medtronic USA, INC. | $150.78 | 2019 | |
| Vertos Medical, INC. | $147.90 | 2022 | |
| Electronic Waveform Lab, INC. | $137.98 | 2020 | |
| Verona Pharma, INC. | $124.94 | 2025 | Ohtuvayre |
| Boston Scientific Corporation | $94.07 | 2025 | General - Pain Management |
| Spinal Elements, INC. | $86.37 | 2024 | |
| Collegium Pharmaceutical, INC. | $67.16 | 2024-2025 | Belbuca |
| Spr Therapeutics, INC | $61.59 | 2024-2025 | Sprint Pns System |
| Si-Bone, INC. | $51.94 | 2022-2023 | |
| Saluda Medical Americas, INC. | $51.46 | 2023-2025 | Evoke Scs, Evoke |
| Avanos Medical | $33.43 | 2024 | Genvisc 850 Sodium Hyaluronate |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossur Americas, INC. | $25.59 | 2025 | Unloader One X |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milind Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.